Market revenue in 2023 | USD 236.0 million |
Market revenue in 2030 | USD 441.7 million |
Growth rate | 9.4% (CAGR from 2023 to 2030) |
Largest segment | Volumetric infusion pumps |
Fastest growing segment | Insulin Infusion Pumps |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Volumetric Infusion Pumps, Syringe Infusion Pumps, Insulin Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient-Controlled Analgesia Infusion Pumps, Implantable Infusion Pumps, Other Infusion Pumps |
Key market players worldwide | Baxter International Inc, B. Braun, Medtronic PLC, Micrel Medical Devices, Boston Scientific Corp, Fresenius SE & Co KGaA, Roche Holding AG, Tandem Diabetes Care Inc, Terumo Corp, Moog Inc A, IRadimed Corp, CareFusion, Smiths Group PLC, Mindray Medical International |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intravenous infusion pumps market will help companies and investors design strategic landscapes.
Volumetric infusion pumps was the largest segment with a revenue share of 16.82% in 2023. Horizon Databook has segmented the UK intravenous infusion pumps market based on volumetric infusion pumps, syringe infusion pumps, insulin infusion pumps, enteral infusion pumps, ambulatory infusion pumps, patient-controlled analgesia infusion pumps, implantable infusion pumps, other infusion pumps covering the revenue growth of each sub-segment from 2018 to 2030.
According to Public Health England, people in certain areas of the UK have the best healthy life in the world, which means the average life expectancy in the country is quite high. However, there is a high prevalence of chronic diseases, mainly comprising ischemic heart disease, lung cancer, stroke, chronic obstructive pulmonary disorder, and Alzheimer’s.
The Medicines and Healthcare products Regulatory Agency (MHRA) regulated all medical devices that enter the UK market. However, after Brexit, the UK’s medical devices are expected to be regulated under the new Medical Devices Regulation (MDR) and In Vitro Diagnostics Regulation (IVDR), currently under transition period.
The UK is the largest country, after Germany, in Europe’s intravenous infusion market, because of its increasing need for ambulatory infusion pumps and patient-controlled analgesia pumps to cater to the controlled medication delivery to patients suffering from chronic diseases.
Horizon Databook provides a detailed overview of country-level data and insights on the UK intravenous infusion pumps market , including forecasts for subscribers. This country databook contains high-level insights into UK intravenous infusion pumps market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account